| ²é¿´: 377 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
xuedaolao½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
¹ØÓÚUSPÒºÏàÉ«Æ×ϵͳÊÊÓÃÐÔ²âÊÔ
|
||
| ÓÐÒ»¸öÔÁÏÒ©£¬ÆäÏà¹ØÎïÖÊÍêÈ«²ÉÓõÄÊÇUSPרÂÛÖй涨µÄHPLC·¨£¬¸ù¾Ý¸½Â¼1226µÄ¹æ¶¨£¬ÐèÒª×öʵ¼ÊʹÓÃÌõ¼þϵÄϵͳÊÊÓÃÐÔ²âÊÔ£¨Users of compendial analytical procedures are not required to validate these procedures when first used in their laboratories, but documented evidence of suitability should be established under actual conditions of use.£©¡£ÎÒÃǽ«Éú²ú¹¤ÒÕÖпÉÄܳöÏÖµÄÔÓÖʽøÐÐÁ˶¨Î»£¬²¢ÔÚ²âÊÔ½á¹ûÖÐÒ»Ò»Áгö£¬²»ÖªµÀÕâÖÖÇé¿öÏÂÓ¦¸ÃÔõôȥȷ֤ʵ¼ÊʹÓÃÌõ¼þϵÄϵͳÊÊÓÃÐÔ£¿ |
» ²ÂÄãϲ»¶
µ÷¼Á
ÒѾÓÐ3È˻ظ´
ҩѧѧ˶326Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ257È˻ظ´
26Ä격ʿÉêÇë
ÒѾÓÐ20È˻ظ´
½Î÷¿Æ¼¼Ê¦·¶´óѧ΢ÉúÎïÌìȻҩÎïÀÏʦ½éÉÜ
ÒѾÓÐ23È˻ظ´
ÇóÖú ±½Á×Áò°·JP
ÒѾÓÐ0È˻ظ´
100½ð±Ò °¢ÄªÎ÷ÁÖ¿ËÀάËá¼ØÆ¬BPÒ©µäÖÐÌáµ½µÄ¿ËÀάËá¾ÛºÏÎï¾ßÌå½á¹¹Ê½ÊÇɶ£¿
ÒѾÓÐ2È˻ظ´
ÉÅʳ²¹³ä¼ÁºÏ¹æÐÔ½»Á÷
ÒѾÓÐ0È˻ظ´
Ò»Ö¾Ô¸Õã´óҩѧÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
¸ßθßѹ·´Ó¦ÇóÖú
ÒѾÓÐ4È˻ظ´
¡¾ÕÐÆ¸¡¿Çå±±£¨¼ÃÄÏ£©ÉúÎï¿Æ¼¼ÕÐÆ¸AIÖÆÒ©Ñз¢¼ÆËãÈ˲Å
ÒѾÓÐ4È˻ظ´
xuedaolao
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5409.5
- É¢½ð: 5
- ºì»¨: 1
- Ìû×Ó: 283
- ÔÚÏß: 17.2Сʱ
- ³æºÅ: 123473
- ×¢²á: 2005-12-05
- ÐÔ±ð: MM
- רҵ: ҩѧ
3Â¥2008-10-23 09:26:10
robbiekean
ľ³æ (ÕýʽдÊÖ)
- DRDEPI: 1
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 2909.1
- É¢½ð: 34
- ºì»¨: 2
- Ìû×Ó: 423
- ÔÚÏß: 66.9Сʱ
- ³æºÅ: 204681
- ×¢²á: 2006-03-02
- ÐÔ±ð: GG
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
¡ï
karl2100(½ð±Ò+1,VIP+0):¶àлָ½Ì£¡
karl2100(½ð±Ò+1,VIP+0):¶àлָ½Ì£¡
|
Èç¹û¸öÂÛ ÒÑÊÕ¼µÄÔÁÏÒ©£¬Ö»ÐèÒª×öVERIFICATION£¬¶ø²»ÊÇVALIDATIONÁË ÆäʵϵͳÊÊÓ¦ÐÔ¿ÉÒÔ´ÓºÜ¶à·½Ãæ¿¼ÂÇ£¬·ÖÀë¶È£¬ÖùЧ£¬¾«Ãܶȵȵȣ¬ÄãÖ»ÐèҪѡÔñ1-2Ïî×öÁ˲¢ÌåÏÖ¸ÃÌõ¼þÏÂÊʺÏ×öÏÂÒ»²½ÑéÖ¤¾Í¿ÉÒÔÁË¡£ ÄÃÎÒÃÇQCÀ´Ëµ°É£¬ÎÒÃǵÄϵͳÊÊÓ¦ÐÔÒ»°ãÑ¡Ôñ±¨¸æ±ê×¼ÈÜÒºµÄ·ÖÀë¶È£¬ÀíÂÛËþ°åÊý£¬²¢¼ÆËãÖØ¸´½øÑùµÄRSD£¬¶øÒ»°ãµÄÏÞ¶ÈÊÔÑéÒ²»áÓв»Í¬µÄÑ¡Ôñ¡£ÄãÒ²¿ÉÒԲο¼FDAµÄ·ÖÎö·½·¨ÑéÖ¤Ö¸ÄÏ£¬×¾¼û£¡ |
2Â¥2008-10-16 20:30:02














»Ø¸´´ËÂ¥
20